Proportion of adult patients with a new CIED with an in-person evaluation within 2 to 12 weeks following implantation.
Measure Specs
General Information
Numerator
This measures assess the number of patients from the denominator with an in-person evaluation within 2-12 weeks following implantation. For the purposes of this measure, an “in-person evaluation” is defined as an in-person interrogation device evaluation either with or without iterative adjustment, as clinically indicated. The in-person evaluation can be provided by any trained physician or Clinically Employed Allied Professional (CEAP) in a designated CIED follow-up clinic, medical institution, or physician office.
Denominator
All Medicare FFS patients with implantation of a new CIED during the reporting period. CIEDs encompassed for this measure are the following devices:
• Pacemakers (PMs)
• Implantable cardioverter-defibrillators (ICDs)
• Cardiac resynchronization devices (CRTs)
Exclusions
Exclude patients with any of the following diagnoses/conditions:
1. Patients with Implantable Loop Recorders or Implantable Cardiovascular Monitors.
2. Patients with pulse generator exchange only.
3. Patients with prior CIED implantation.
4. Patient preference for other or no treatment.
Measure Record
Point of Contact
© 2014 Heart Rhythm Society. All Rights Reserved.
Public Comments